KUALA LUMPUR: A Pakatan Harapan MP questioned the “ridiculous decision” made by the government to not administer intravenous (IV) Vitamin C treatment for Covid-19 patients, while opting for more expensive medication like Molnupiravir.
Dr Azman Ismail (PH-Kuala Kedah) said that it should not be an issue for Malaysia to start administering Vitamin C to Covid-19 patients as their Chinese counterparts have started doing so in Wuhan. He said there is plenty of scientific evidence to prove the efficacy of such treatment.
“There are scientific papers published in the Journal of the American Medical Association and New England Journal on administering IV Vitamin C at a higher rate of 6-8mg per day to those who are in Category 1-2 of infection.
“China has been administering 24mg per day for serious Covid-19 patients in Category 4-5,” added Azman.
Azman also claimed that the advice given by a health ministry unit that consuming more than 100mg of Vitamin C per day is harmful as ridiculous.
“There is no evidence to prove that administering more than 100-200mg of Vitamin C is harmful to our internal organs. Vitamin C is just like water,” said Azman.
A few days ago, news agency Australian Associated Press quoted experts saying that there is no “good evidence” that Vitamin C can prevent any respiratory virus, or even Covid-19 for that matter.
Azman added that Australia had been administering 60mg of Vitamin C per day to serious Covid-19 patients.
He also questioned the government’s decision to opt for an expensive drug like Molnupiravir, which is developed by Merck Sharp & Dohme, when there was a cheaper alternative like the IV Vitamin C treatment.
“We are ignoring simple things, but are quick to plan on purchasing Molnupiravir, an expensive drug that will cost RM3,000 to treat each patient,” added Azman.
CLICK HERE FOR THE LATEST DATA ON THE COVID-19 SITUATION IN MALAYSIA